✦ LIBER ✦

Immunogenicity and reactogenicity of a combined DTPw-hepatitis B vaccine in Lithuanian infants

✍ Scribed by V. Usonis; V. Bakasenas; D. Taylor; P. Vandepapeliere; P. Vandepapeliere

Book ID: 105411250
Publisher: Springer
Year: 1996
Tongue: English
Weight: 525 KB
Volume: 155
Category: Article
ISSN: 0340-6997
DOI: 10.1007/bf01953936

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined Vaccination against Hepatitis A

Combined Vaccination against Hepatitis A, Hepatitis B, and Typhoid Fever: Safety, Reactogenicity, and Immunogenicity

✍ Stephan Proell; Hubert Maiwald; Hans-Dieter Nothdurft; Roland Saenger; Jens Voll 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Immunogenicity, reactogenicity and adher

Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users

✍ Fabio Lugoboni; GianLuca Quaglio; Benedetta Pajusco; Paolo Civitelli; Luisa Roma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Primary course immunogenicity and reacto

Primary course immunogenicity and reactogenicity of a new diphtheria-tetanus-whole cell pertussis vaccine (DTPw)

✍ T NOLAN; G HOGG; M-A DARCY; J VARIGOS; J McEWEN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

A Single Dose, Combined Vaccine against

A Single Dose, Combined Vaccine against Typhoid Fever and Hepatitis A: Consistency, Immunogenicity and Reactogenicity

✍ J. Beran; M. Beutels; K. Levie; P. van Damme; I. Dieussaert; M. Gillet; C. van H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Immunogenicity of a recombinant hepatiti

Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs

✍ P. M. Mannucci; A. Gringeri; M. Morfini; R. De Biasi; M. C. Tirindelli; G. Tampo 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 2 views

Safety and immunogenicity of a recombina

Safety and immunogenicity of a recombinant hepatitis B vaccine

✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.